Taliglucerase Alfa

CHEMBL1964120 Phase 4 Approved Enzyme
Half-Life
Bioavailability
Protein Binding
Molecular Weight
g/mol
LogP
Phase
4

Taliglucerase alfa is a recombinant form of the enzyme glucocerebrosidase, produced in plant cell culture, used as enzyme replacement therapy for Gaucher disease type 1. It works by breaking down accumulated glucocerebroside in macrophages, reducing organomegaly, cytopenias, and bone complications. It represents the first plant-cell-derived recombinant therapeutic protein approved for human use.

Mechanism of Action

As a recombinant protein, it replicates the function of the naturally occurring human protein, supplementing or replacing deficient endogenous production to restore normal physiological activity.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mechanism

As a recombinant protein, it replicates the function of the naturally occurring human protein, supplementing or replacing deficient endogenous production to restore normal physiological activity.

HBD / HBA

- / -

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Frequently Asked Questions

Taliglucerase alfa is a recombinant form of the enzyme glucocerebrosidase, produced in plant cell culture, used as enzyme replacement therapy for Gaucher disease type 1. It works by breaking down accumulated glucocerebroside in macrophages, reducing organomegaly, cytopenias, and bone complications. It represents the first plant-cell-derived recombinant therapeutic protein approved for human use.

As a recombinant protein, it replicates the function of the naturally occurring human protein, supplementing or replacing deficient endogenous production to restore normal physiological activity.

Yes, Taliglucerase Alfa is an approved drug. It has reached clinical phase 4. It is classified as a Enzyme.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1964120. Open-access bioactivity database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-02-27.

Medical Disclaimer

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.